Latigo Biotherapeutics Archives - Inside Precision Medicine

Inside Precision Medicine Next-Generation Non-Opioid Pain Relievers Advance

woman holding her wrist pain because using smartphone or computer long time. De Quervain's tenosynovitis, Intersection Symptom, Carpal Tunnel Syndrome or Office syndrome concept. To illustrate tendon damage

News & Features

Next-Generation Non-Opioid Pain Relievers Advance

February 15, 2024

Related Content

Lilly Pays up to $2.5B for Selective PI3Kα Inhibitor

Lilly Pays up to $2.5B for Selective PI3Kα Inhibitor

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Questions Raised over Opioid Use Disorder Algorithm

Questions Raised over Opioid Use Disorder Algorithm

Potential Action: SiteOne’s $100M Series C to Advance Non-Opioid Pain Drugs

Potential Action: SiteOne’s $100M Series C to Advance Non-Opioid Pain Drugs